Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Anaplan, Inc. (PLAN)
|
Add to portfolio |
|
|
Price: |
$45.05
| | Metrics |
OS: |
150.5
|
M
| |
-85
|
% ROE
|
Market cap: |
$6.78
|
B
| |
|
|
Net cash:
|
$304
|
M
| |
$2.02
|
per share
|
EV:
|
$6.48
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($176)
|
M
| |
|
|
EBIT
|
($211)
|
M
| |
|
|
EPS |
($1.43)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-31-18 | Jan-31-17 | Jan-31-16 |
Revenues | 592.2 | 447.8 | 348.0 | 240.6 | 168.3 | 120.5 | 71.5 |
Revenue growth | 32.3% | 28.7% | 44.6% | 42.9% | 39.7% | 68.5% | |
Cost of goods sold | 156.3 | 109.0 | 90.8 | 67.4 | 52.0 | 39.4 | 30.5 |
Gross profit | 435.8 | 338.8 | 257.2 | 173.2 | 116.4 | 81.1 | 41.0 |
Gross margin | 73.6% | 75.7% | 73.9% | 72.0% | 69.1% | 67.3% | 57.4% |
Sales and marketing | 377.4 | 302.0 | 250.4 | 176.3 | 100.7 | 73.7 | 55.3 |
Research and development | 153.5 | 100.5 | 68.4 | 49.0 | 30.9 | | 19.3 |
General and administrative | 105.7 | 90.0 | 86.9 | 76.2 | 30.7 | | 19.3 |
EBITA | -200.7 | -153.8 | -148.4 | -128.3 | -45.7 | -38.9 | -52.9 |
EBITA margin | -33.9% | -34.3% | -42.7% | -53.3% | -27.2% | -32.3% | -73.9% |
Amortization of intangibles | | | | | 0.2 | | |
EBIT | -200.7 | -153.8 | -148.4 | -128.3 | -45.9 | -38.9 | -52.9 |
EBIT margin | -33.9% | -34.3% | -42.7% | -53.3% | -27.3% | -32.3% | -73.9% |
Pre-tax income | -207.7 | -149.9 | -144.8 | -127.8 | -46.3 | -39.7 | -54.1 |
Income taxes | -4.1 | 4.1 | 4.5 | 3.2 | 1.3 | 0.5 | 0.1 |
Tax rate | 2.0% | | | | | | |
Net income | -203.6 | -154.0 | -149.2 | -131.0 | -47.6 | 0.0 | -54.2 |
Net margin | -34.4% | -34.4% | -42.9% | -54.4% | -28.2% | 0.0% | -75.8% |
|
Diluted EPS | ($1.39) | ($1.10) | ($1.15) | ($2.46) | ($2.51) | $0.00 | ($4.62) |
Shares outstanding (diluted) | 146.3 | 139.5 | 129.8 | 53.3 | 19.0 | 13.8 | 11.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|